Clinical Trial

SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter prospective observational study lead by the FIL on sarcopenia and sGA as possible predictors of efficacy and toxicity outcomes in patients undergoing CAR-T cells treatment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-27; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2024-06-14
Trial Details
NCT Number NCT06156774
Lead Sponsor Fondazione Italiana Linfomi - ETS
Collaborators: Kite, A Gilead Company
Conditions Non-hodgkin Lymphoma,B Cell
Enrollment 130 participants
Start Date 2024-04-18
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-08